Xenon Non Current Assets Total from 2010 to 2024
| XENE Stock | USD 43.75 0.56 1.30% |
Non Current Assets Total | First Reported 2012-09-30 | Previous Quarter 140.1 M | Current Value 319.8 M | Quarterly Volatility 65.6 M |
Check Xenon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xenon main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 6.7 M or Selling General Administrative of 48.9 M, as well as many exotic indicators such as Price To Sales Ratio of 239, Dividend Yield of 0.0 or PTB Ratio of 3.18. Xenon financial statements analysis is a perfect complement when working with Xenon Pharmaceuticals Valuation or Volatility modules.
Xenon | Non Current Assets Total |
Latest Xenon Pharmaceuticals' Non Current Assets Total Growth Pattern
Below is the plot of the Non Current Assets Total of Xenon Pharmaceuticals over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Xenon Pharmaceuticals' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xenon Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Non Current Assets Total | 10 Years Trend |
|
Non Current Assets Total |
| Timeline |
Xenon Non Current Assets Total Regression Statistics
| Arithmetic Mean | 56,987,920 | |
| Geometric Mean | 7,149,645 | |
| Coefficient Of Variation | 204.60 | |
| Mean Deviation | 85,139,739 | |
| Median | 2,831,000 | |
| Standard Deviation | 116,596,051 | |
| Sample Variance | 13594.6T | |
| Range | 334.8M | |
| R-Value | 0.69 | |
| Mean Square Error | 7664.3T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 17,996,952 | |
| Total Sum of Squares | 190324.9T |
Xenon Non Current Assets Total History
About Xenon Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Xenon Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Xenon Pharmaceuticals investors use historical funamental indicators, such as Xenon Pharmaceuticals's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Xenon Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Xenon Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Xenon Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Xenon Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Xenon Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Assets Total | 319.8 M | 335.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports:Check out the analysis of Xenon Pharmaceuticals Correlation against competitors. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Xenon Stock analysis
When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Xenon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.73) | Quarterly Revenue Growth (1.00) | Return On Assets (0.16) | Return On Equity (0.22) |
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.